A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndromeGail J. Roboz, Daniel J. DeAngelo, Pinkal Desai et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 35
Pharmacokinetic (PK) interactions between capecitabine (X), oxaliplatin (O) and bevacizumab (A) when used in combination for first-line treatment of metastatic colorectal cancer (MCRC)Barbara J. Brennan, S Choudhury, A. Gandhi et al.|Journal of Clinical Oncology|2007Cited by 5